Investing Profile

Kabeer Aziz

InvestorVCFounder
Partner at Adjuvant Capital
adjuvantcapital.com/team/New York, New York
Photo of Kabeer Aziz, Partner at Adjuvant Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
New York University - Leonard N. Stern School of Business Network
119 CONNECTIONS
NYU Stern School of Business Network
112 CONNECTIONS
Greenhill & Co. Network
17 CONNECTIONS
cb
$100K - $5.0M
$1.5M
6
$300M
CompanyStageDateRound SizeTotal Raised
Minervax
Series UnknownOct 2023$57M
Series CDec 2022$23M
Series BDec 2020$58M
$140M
Co-investors: Christopher Gagliardi (Sanofi Ventures), Veronica Gambillara Fonck (Pureos Bioventures), Vincent Brichard
LimmaTech Biologics
Series AOct 2023$36M
$36M
Pulmocide
Series CDec 2022$52M
Series CMay 2021$92M
$140M
Analyst Greenhill & Co.Present
Associate Metalmark CapitalPresent
Senior Associate Global Health Investment FundPresent
Director Quantoom BiosciencesPresent
Partner Adjuvant CapitalPresent
Director AN2 TherapeuticsPresent
Director Minervax ApSPresent
Director Frontier Nutrition, Inc.Present
Director PulmocidePresent
Board Observer Curevo VaccinePresent
Director ChromaCode, Inc.Present
NYU Stern School of Business B.S. Finance & Economics
New York University - Leonard N. Stern School of Business B.S. Finance & Economics